Growth momentum Override is expanding in the chronic pain management market with recent leadership change and ongoing partnerships, signaling a readiness to scale. Medium-sized team and seed-funded growth suggest an opportunity to position value propositions for healthcare networks and payers seeking integrated, non-opioid pain care.

Strategic partnerships Continued collaboration with health systems and referral networks (e.g., Meritus Health partnership, Bicycle Health referral relationships) indicate a proven channel for patient access. Target similar health systems and specialty networks to expand patient inflow and cross-promote digital chronic pain programs.

Digital health tech Technology stack featuring cloud infrastructure, communications, payments, and security (AWS, Stripe, OneTrust, Intercom) supports scalable, compliant patient experiences. Opportunities exist to upsell integration services with existing EHRs, telehealth platforms, and patient engagement tools for health networks.

Funding signals Seed funding rounds totaling several million from notable VCs reflect investor confidence and potential for rapid product development and market expansion. Leverage this traction to engage with potential partners and show financial viability to payers and hospital systems.

Revenue potential Current revenue range in the hundreds of millions positions Override as a midsize growth company with strong market demand for non-opioid chronic pain care. Focus on enterprise sales to health plans, large clinics, and integrated delivery networks seeking cost-effective pain management solutions.